Several key developments in the health sector involve major pharmaceutical companies navigating growth challenges and ...

Cencora, Inc. COR is well-poised for growth ... Zacks Investment Research Image Source: Zacks Investment Research COR’s bottom line is anticipated to improve 10.4% over the next five years.

Cencora, Inc. COR is well-poised for growth ... The company has a market capitalization of $49.31 billion. Image Source: Zacks Investment Research COR’s bottom line is anticipated to improve ...

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern. Shares of this Zacks Rank #2 (Buy) ...

Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...

The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...

PC hardware is nice, but it’s not much use without innovative software. I’ve been reviewing software for PCMag since 2008, and I still get a kick out of seeing what's new in video and photo ...